NCBI Taxonomy: 753479

Setomorphinae (ncbi_taxid: 753479)

found 10 associated metabolites at subfamily taxonomy rank level.

Ancestor: Tineidae

Child Taxonomies: Lindera, Setomorpha

Linderalactone

NCGC00385309-01_C15H16O3_(1R)-3,8-Dimethyl-5,14-dioxatricyclo[10.2.1.0~2,6~]pentadeca-2(6),3,8,12(15)-tetraen-13-one

C15H16O3 (244.1099386)


Isolinderalactone is a member of benzofurans. It has a role as a metabolite. Isolinderalactone is a natural product found in Neolitsea villosa, Neolitsea hiiranensis, and other organisms with data available. A natural product found in Neolitsea daibuensis. Linderalactone is a natural product found in Neolitsea umbrosa, Neolitsea villosa, and other organisms with data available. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity through the inhibition of VEGFR2 activation in endothelial cells[1]. Isolinderalactone suppresses the expression of B-cell lymphoma 2 (Bcl-2), survi Isolinderalactone suppresses human glioblastoma growth and angiogenic activity through the inhibition of VEGFR2 activation in endothelial cells[1]. Isolinderalactone suppresses the expression of B-cell lymphoma 2 (Bcl-2), survi Linderalactone is an important sesquiterpene lactone isolated from Lindera aggregata. Linderalactone inhibits cancer growth by modulating the expression of apoptosis-related proteins and inhibition of JAK/STAT signalling pathway. Linderalactone also inhibits the proliferation of the lung cancer A-549 cells with an IC50 of 15 μM[1][2]. Linderalactone is an important sesquiterpene lactone isolated from Lindera aggregata. Linderalactone inhibits cancer growth by modulating the expression of apoptosis-related proteins and inhibition of JAK/STAT signalling pathway. Linderalactone also inhibits the proliferation of the lung cancer A-549 cells with an IC50 of 15 μM[1][2].

   

Lindenenone

(5aS,6aR,6bS)-6,6a,6b,7-Tetrahydro-3,5,6b-trimethylcycloprop[2,3]indeno[5,6-b]furan-4(5aH)-one

C15H16O2 (228.1150236)


   

isolinderalactone

isolinderalactone

C15H16O3 (244.1099386)


Isolinderalactone suppresses human glioblastoma growth and angiogenic activity through the inhibition of VEGFR2 activation in endothelial cells[1]. Isolinderalactone suppresses the expression of B-cell lymphoma 2 (Bcl-2), survi Isolinderalactone suppresses human glioblastoma growth and angiogenic activity through the inhibition of VEGFR2 activation in endothelial cells[1]. Isolinderalactone suppresses the expression of B-cell lymphoma 2 (Bcl-2), survi

   

(5r,6r)-6-ethenyl-3,6-dimethyl-5-(prop-1-en-2-yl)-5,7-dihydro-4h-1-benzofuran

(5r,6r)-6-ethenyl-3,6-dimethyl-5-(prop-1-en-2-yl)-5,7-dihydro-4h-1-benzofuran

C15H20O (216.151407)


   

(1s,9s,10r,12s)-4-(methoxymethyl)-9-methyl-13-methylidene-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]trideca-3(7),4-diene

(1s,9s,10r,12s)-4-(methoxymethyl)-9-methyl-13-methylidene-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]trideca-3(7),4-diene

C16H20O2 (244.14632200000003)


   

(4as,8ar)-3,8a-dimethyl-5-methylidene-4h,4ah,6h,9h-naphtho[2,3-b]furan

(4as,8ar)-3,8a-dimethyl-5-methylidene-4h,4ah,6h,9h-naphtho[2,3-b]furan

C15H18O (214.1357578)


   

(4as,8ar,9as)-3,8a-dimethyl-5-methylidene-4h,4ah,6h,9h,9ah-naphtho[2,3-b]furan-2-one

(4as,8ar,9as)-3,8a-dimethyl-5-methylidene-4h,4ah,6h,9h,9ah-naphtho[2,3-b]furan-2-one

C15H18O2 (230.1306728)


   

(5s,6s,7as)-6-ethenyl-3,6-dimethyl-5-(prop-1-en-2-yl)-4,5,7,7a-tetrahydro-1-benzofuran-2-one

(5s,6s,7as)-6-ethenyl-3,6-dimethyl-5-(prop-1-en-2-yl)-4,5,7,7a-tetrahydro-1-benzofuran-2-one

C15H20O2 (232.14632200000003)


   

(9r,10s,12r)-4-(methoxymethyl)-9,13-dimethyl-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]trideca-1(13),3(7),4-triene

(9r,10s,12r)-4-(methoxymethyl)-9,13-dimethyl-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]trideca-1(13),3(7),4-triene

C16H20O2 (244.14632200000003)


   

(3z)-5,10-dimethyl-8,14,16-trioxatetracyclo[10.2.2.0¹,¹³.0⁷,¹¹]hexadeca-3,7(11),9-trien-15-one

(3z)-5,10-dimethyl-8,14,16-trioxatetracyclo[10.2.2.0¹,¹³.0⁷,¹¹]hexadeca-3,7(11),9-trien-15-one

C15H16O4 (260.1048536)